Page 205 - Syndipharma
P. 205
Arya Pharmaceutical Co.
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Dosage Strength
Type Product or brand name Indication Status
form (mg)
Antianginal,
HM Diltiazem ___ Tablet 60/ 120 Antihypertensive, In production
Antiarrhythmic
Antianginal, Vaso-
HM Isosorbide Isocor® E.R. Tablet 10/ 40 dilator, Conges- In production
tive heart failure
Antihypertensive,
benign prostat-
HM Terazosin ___ Tablet 2/ 5 In production
ic hyperplasia
therapy
Anti-glhypergly-
HM Metformin ___ Tablet 500 In production
emic
Gastric acid pump
HM Pantoprazole Pantosec® Tablet 40 In production
inhibitor, antiulcer
Bismuth
HM Bismuthan® Tablet 120 Antiulcer In production
Subcitrate
Histamine H2- re-
HM Ranitidine Ary-Tac® Tablet 150 In production
ceptor antagonist
HM Mebeverine Colocap® Capsule 200 Antispasmodics Registered
HM S-Omeprazole ESO-CAP® Capsule 20/ 40 Gastrointestinal In production
HM Mesalazine ___ Tablet 500 Anti-inflammatory In production
HM Levocetirizine Cetizox® Tablet 5 Anti-Histaminic Registered
HM Loratadine ___ Scored Tablet 10 Anti-Histaminic Registered
HM Cetirizine ___ Tablet 10 Anti-Histaminic In production
Anti-thrombotic,
HM Clopidogrel Arvix® Tablet 75 platelet aggrega- Registered
tion inhibitor
HM Ciprofloxacin ___ Tablet 500 Anti-bacterial In production
HM Azithromycin ___ Capsule 250 Anti-infective In production
HM Duloxetine ___ Capsule 20 Antidepressant Registered
204